Concepedia

Enrique Pérez‐Cárdenas

EP

Statistics

Publications

29

Citations

2.3K

H-Index

24

Active since

1999

Affiliations

Instituto Nacional de Cancerología(Current)

Universidad Nacional Autónoma de México

Universidad de Cuautitlán Izcalli

Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional

National Institute of Genomic Medicine

Enrique Pérez‐Cárdenas is an author at Instituto Nacional de Cancerología specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

1999–2019

29

Publications

29

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors

Myrna Candelaria, Dolores Gallardo‐Rincón, Claudia Arce et al. · Annals of Oncology · 2007 · 252 citations

, , +17

Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy.

Blanca Segura‐Pacheco, Catalina Trejo‐Becerril, Enrique Pérez‐Cárdenas et al. · PubMed · 2003 · 206 citations

, , +17

Ether a go-go Potassium Channels as Human Cervical Cancer Markers

Luz María Barajas Farias, Deysi Bermúdez Ocaña, Fernando Larrea et al. · Cancer Research · 2004 · 160 citations

, , +14

A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes

Pilar Zambrano, Blanca Segura‐Pacheco, Enrique Pérez‐Cárdenas et al. · BMC Cancer · 2005 · 150 citations · Full text

, , +17

A Proof-Of-Principle Study of Epigenetic Therapy Added to Neoadjuvant Doxorubicin Cyclophosphamide for Locally Advanced Breast Cancer

Claudia Arce, Carlos Pérez‐Plasencia, Aurora González‐Fierro et al. · PLoS ONE · 2006 · 144 citations · Full text

, , +16

1–5 of 29